Trial NCT03608358

View at ClinicalTrials.gov 
Org. Study IDs: D1683C00008

Last trial update was posted on 2022-05-31

MeSH Interventions

Dapagliflozin Metformin Saxagliptin

MeSH Conditions

Diabetes Mellitus, Type 2

Other Conditions

Type 2 Diabetes Mellitus

Stopping Reasons

Sponsor decided to stop commercialization of QTERNMet/Qtrilmet and to stop all related ongoing activities/studies for business reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID